Provided by Tiger Trade Technology Pte. Ltd.

HARBOR HEALTH CARE ETF

32.96
-0.3796-1.14%
Post-market: 33.050.0854+0.26%16:10 EDT
Volume:1K
Turnover:46.07K
Market Cap:42.03M
PE:- -
High:33.17
Open:33.17
Low:32.95
Close:33.34
52wk High:35.61
52wk Low:27.50
Shares:1.28M
Float Shares:1.28M
Volume Ratio:0.18
T/O Rate:0.11%
Dividend:0.08
Dividend Rate:0.23%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Biomarin Pharmaceutical Shares up 5.6% Premarket After Co Announces Global Settlement with Ascendis Pharma

THOMSON REUTERS
·
Aug 31

BioMarin Settles Patent Lawsuits With Ascendis Pharma Over Yuviwel

MT Newswires Live
·
Aug 31

Biomarin Pharmaceutical - to Dismiss Itc Investigation; All Ip Claims Resolved Including Litigation in Multiple Countries

THOMSON REUTERS
·
Aug 31

Will Japan’s First IMCIVREE Approval in Hypothalamic Obesity Change Rhythm Pharmaceuticals’ (RYTM) Narrative

Simply Wall St.
·
Aug 31

Protagonist announces Takeda received U.S. FDA approval for MIMRYLO

TIPRANKS
·
Aug 31

Gilead (GILD) Stock Stays Cheap After A 143% Five Year Run

Simply Wall St.
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

Takeda Wins FDA Nod for First-in-Class Polycythemia Vera Therapy MIMRYLO

TIPRANKS
·
Aug 29

Takeda receives FDA approval of NDA for Mimrylo

TIPRANKS
·
Aug 29

India's GLP-1 Weight-Loss Drugs Stall at $14 Monthly Despite High Diabetes Rates

Deep News
·
Aug 29

Gilead Sciences Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Aug 29

Eli Lilly (LLY) Wins FDA Approval For Mounjaro Heart Risk Reduction

Simply Wall St.
·
Aug 29

Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo

TIPRANKS
·
Aug 29

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live
·
Aug 28

Rhythm Pharmaceuticals Initiated at Hold by Deutsche Bank

Dow Jones
·
Aug 28

Rhythm Pharmaceuticals, Inc. : Deutsche Bank Initiates Coverage with Hold Rating and Target Price $120

THOMSON REUTERS
·
Aug 28

FDA Approves Lilly's Mounjaro to Cut Cardiovascular Event Risk in High-Risk Type 2 Diabetes Adults

Reuters
·
Aug 28

FDA Approves Lilly's Mounjaro (Tirzepatide) to Reduce Cardiovascular Risk in Adults with Type 2 Diabetes

THOMSON REUTERS
·
Aug 28

Rhythm Pharmaceuticals initiated with a Hold at Deutsche Bank

TIPRANKS
·
Aug 28

Dow Jones Top Company Headlines at 11 PM ET: Judge Rules Trump Administration's Blacklisting of Anthropic was Unlawful | Nvidia ...

Dow Jones
·
Aug 28